---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-21-000024"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2021-08-04T23:59:59+00:00"
generated_at: "2026-06-29T22:56:49.318016+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ICU Medical Q2 revenue $321.7M (+6% YoY); adj. EPS $1.88 vs $1.65

## Summary
- GAAP net income $28.4M ($1.31 diluted EPS) vs $18.9M ($0.88) a year ago.
- Adjusted EBITDA of $66.9M, up from $58.1M in Q2 2020.
- GAAP gross margin improved to 38% from 35% year-over-year.
- Company updated FY 2021 guidance in the release.

## SEC filing metadata
- accession: 0000883984-21-000024
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2021-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398421000024/0000883984-21-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398421000024/icui-20210804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-21-000024
- JSON: https://secwatch.observer/filing/0000883984-21-000024.json
- Plain text: https://secwatch.observer/filing/0000883984-21-000024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.